[HTML][HTML] The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

D Yang, Y Zhang, HG Nguyen… - The Journal of …, 2006 - Am Soc Clin Investig
D Yang, Y Zhang, HG Nguyen, M Koupenova, AK Chauhan, M Makitalo, MR Jones…
The Journal of clinical investigation, 2006Am Soc Clin Investig
Adenosine has been described as playing a role in the control of inflammation, but it has not
been certain which of its receptors mediate this effect. Here, we generated an A2B
adenosine receptor–knockout/reporter gene–knock-in (A2BAR-knockout/reporter gene–
knock-in) mouse model and showed receptor gene expression in the vasculature and
macrophages, the ablation of which causes low-grade inflammation compared with age-,
sex-, and strain-matched control mice. Augmentation of proinflammatory cytokines, such as …
Adenosine has been described as playing a role in the control of inflammation, but it has not been certain which of its receptors mediate this effect. Here, we generated an A2B adenosine receptor–knockout/reporter gene–knock-in (A2BAR-knockout/reporter gene–knock-in) mouse model and showed receptor gene expression in the vasculature and macrophages, the ablation of which causes low-grade inflammation compared with age-, sex-, and strain-matched control mice. Augmentation of proinflammatory cytokines, such as TNF-α, and a consequent downregulation of IκB-α are the underlying mechanisms for an observed upregulation of adhesion molecules in the vasculature of these A2BAR-null mice. Intriguingly, leukocyte adhesion to the vasculature is significantly increased in the A2BAR-knockout mice. Exposure to an endotoxin results in augmented proinflammatory cytokine levels in A2BAR-null mice compared with control mice. Bone marrow transplantations indicated that bone marrow (and to a lesser extent vascular) A2BARs regulate these processes. Hence, we identify the A2BAR as a new critical regulator of inflammation and vascular adhesion primarily via signals from hematopoietic cells to the vasculature, focusing attention on the receptor as a therapeutic target.
The Journal of Clinical Investigation